Introduction
The Research Triangle Institute (RTI), in cooperation with the U.S. Environmental Criteria and Assessment Office, Research Triangle Park (ECAO-RTP), has developed a risk characterization framework to provide a systematic approach for analyzing and presenting study results that estimate the health risks for indoor air pollutants. The framework was initially developed for characterizing both carcinogenic and noncarcinogenic health risks. However, due to several substantive differences between these types of health risks, two separate frameworks have been developed. This paper presents the risk characterization framework for noncancer health risks and a preliminary application of the framework to a complex mixture of volatile organic compounds from indoor sources.
Noncancer Risk Characterization Framework
The risk characterization framework for noncancer health effects is presented in Figure 1 . It provides a means to display the complexity ofcharacterizing noncancer health effects, the issues involved, the data and information needs, and the relationship among these data elements and issues. The four elements ofrisk assessment, hazard identification, exposure assessment, doseresponse assessment, and risk characterization, are represented in the framework. The risk assessment process as represented in the framework is further subdivided into 10 elements (represented by columns B through Kin Figure 1 ). This allows for greater detail in examining the overall risk estimation process. Hazard identification is covered in columnsBthroughJof Figure  1 in a primarily qualitative manner; exposure assessment is covered by columns B through F, dose-response assessment by columns G and H, and risk characterization by columns Ithrough K, though it actually integrates information from all previous steps. The framework has been subdivided into the four groupings at the top ofthe figuretoexhibit data needs for characterizing exposure (columns C-E), dose (columns E-G), individual health effects (columns G-1) and population health effects (columns I-K).
The major elements of noncancer risk characterization are outlined and summarized below. The concepts and issues presented represent the ideal in terms ofthe information and data needed to conduct a thorough risk characterization ofnoncancer health effects. The issues and data needs presented in the framework include both standard EPA methods (for noncancer and complex mixture risk assessment) and state-of-the-art, characterization. As the major issues related to noncancer health effects is the nature of the effects themselves, discussion of the framework will start with the goals ofthe risk characterization, how individual and population health effects are described (columns I-K of Figure 1 ). Discussion will then focus on the other columns in order (columns C-H) and how the nature of noncancer health effects influences these components.
Risk Characterization
Characterization of noncancer health effects differs (colums l-K of Figure 1 ) from those of cancer in the breadth of effects covered and in the detail in which they are characterized. Cancer risks are typically characterized as the number ofcases ofcancer attributed to the exposure in question. However, noncancer effects consist of multiple end points each having varying degrees of severity. Additionally, not all individuals may be at risk, or specific varying susceptibilities may exist within a population. Risk for noncancer effects ideally would be expressed as distributions within a population by effect and severity rather than a single estimate of increased cases.
Individual Health Effects
The first important factor in characterizing noncancer risks is the nature ofthe health effects (column I in Figure 1 
Affected Population
Individual responses vary greatly within a population (column J of Figure 1 ). The susceptibility of an individual to a specific Q. z^w. 74W; 147 122 1Inc,dence adverse effect dictates the level of a response. Individual susceptibilities are believed to follow some statistical distribution within a population. Additionally, susceptibility may be rooted in personal behavior, activities, and exposures associated with those activities. Individual sensitivities are distributed among a population and can include sensitive subpopulations (e.g., children in the case of low-level lead exposure), genetic predispositions (e.g., enzyme deficiencies), other exposures (e.g., smoking), preexisting conditions (e.g., asthma), and illness.
It is desirable to characterize exposed populations in column J on the basis oftheir sensitivities. This is above and beyond what is typically done for cancer risk assessment. Calculation of population risks would, therefore, have to correlate information on specific susceptibility and disease. The prevalence of specific susceptibilities within a population would identify the affected portion ofthe exposed population and would be presented in column J. Information presented in this column would include the distribution of general susceptibility for each effect.
Population Health Effects
Population risk estimates would be presented in column Kof Figure 1 as the distribution of effects and severity within the population. Population incidence estimates are derived from individual response data, information on the distribution ofsusceptibility, and data on specific susceptibilities.
Exposure Assessment
Noncancer effects are generally tied more directly to actual exposure patterns and the associated dose than are cancer effects. As a result, greater detail is desirable for the exposure assessment. The details needed for conducting exposure assessments ofnoncarcinogens are discussed below and follow the organization of the columns of the framework shown in Figure 1 .
Pollutant Concentration. Some indoor air pollutant sources are constant, resulting in an equilibrium with regard to pollution concentrations (column C of Figure 1 ). In such cases, a single value for pollutant concentration, deternined by direct measurement or estimated from models, can be used to calculate exposure. However, most indoor air pollutant concentrations are transitory or episodic and are dependent on the pollutant source, its use and environmental and building conditions. Indoor air concentrations due to an individual source or activity (use) would tend to follow one ofthe general profiles shown in Figure 2 . The actual shape of the decay curve is dependent on emission rate, temperature, humidity, and ventilation. The duration ofthe profile may vary greatly from several days or weeks (e.g., carpet installation or other building renovations) to minutes (e.g., use of household products). The overall concentration profile would be the aggregate of all individual profiles. Dose-response modeling for noncancer effects generates a need for detailed concentration data as opposed to average concentrations. Ideally, infonnation that should be included in column C are peak and average concentrations (either from measurement or model estimation) and, ifpossible, a concentration profile.
Averages may also prove useful, but the selection of the appropriate averaging time can be critical to the characterization Figure 1 for each of the pollutants. These exposure estimates may be derived from direct monitoring data or through indirect methods such as integrating time-activity pattern data with pollutant concentrations in the various microenvironments. Peak exposures are important for comparison to threshold values and certain dose-response functions. Also, the timing of exposures with respect to each other may be an important aspect ofthe exposure pattern when one is concerned with sensitization.
Dose-Response Assessment
Dose-response assessments (columns F-H of Figure 1 ) for noncarcinogens have typically focused on the identification ofa threshold below which no adverse health effects are observed and the derivation of exposure levels that are considered to protect human health based on these thresholds. Little attention has been directed to deriving dose-response relationships due primarily to the complexity ofthese relationships, including the need to address multiple end points, multiple organs, and varying degrees of severity (6).
Dose Assessment
Noncancer effects are organ specific, which may require greater emphasis on pharmacokinetic modeling and relevant conversion factors (column Fof Figure 1 ) to calculate systemic dose or delivered dose to specific target organs. Dose is presented in column Gof Figure 1 , calculated as organ burden or as a total body dose, and presented for several time periods; as peak, cumulative, and/or average associated with a given activity. Biomarkers, ifavailable, can also be used to estimate actual dose, reducing the need for detailed exposure profiles. Biomarkers provide no information on exposure patterns and sources ofexposure, except for a small number of sources such as environmental tobacco smoke.
Information presented in column F would include relevant conversion factors, including pharmacokinetic factors. Information presented in column Gwould include peak, cumulative, and average dose, and, if possible, peak, cumulative and average organ burden. This information would be presented for each of the pollutants being evaluated.
Dose-Response Factors
Noncancer effects involve multiple target organs, each having its own dose-response relationship and range ofeffects ofvarying degrees of severity for each pollutant. Ideally, these multiple dose-response factors could be represented in column H of Figure 1 . Additionally, indoor air problems are characterized by multiple compounds, each ofwhich would have their own doseresponse functions and may predict a range of severity ofeffects (6) .
Toxicological data can typically be divided into three categories, quantal, graded, and continuous (7) (8) (9) . Quantal data express incidence and are generally expressed in terms ofnumbers of individuals affected as a function ofdose. Graded data, though not as commonly used, are a type ofquantal data but also include judgment or measure ofseverity ofadverse effects as a function ofdose (7) . For example, graded data may be expressed in terms of identifying pathologies (e.g., fatty infiltration in liver cells to liver necrosis). Continuous data represent the magnitude or intensity of a response within an individual and measures the change in some value of a biological indicator as a function of dose. All types of data can be fit into a dose-response model, though the actual models would differ (8) . Therefore, the characterization ofthe risk is dependent on which type ofdata is used. The framework is flexible enough to accommodate all three types ofdose-response data and their subsequent models.
Another element unique to noncancer effects is the concept of thresholds for adverse effects. While there is still substantial debate as to what effect should be the basis for defining a threshold (i.e., change in biological indicator or clinical effect), the existence ofthresholds is not contested. These thresholds differ according to the organ and effect studied. The framework represents these thresholds either alone or as the benchmark for the dose-response relationship. The thresholds reported in column H can be more specific than the commonly used protective concentrations, which are based on threshold measurements such as acceptable daily intakes or reference doses (9) . The RfD is an estimate (within an order of magnitude) of the daily exposure to the human population (including sensitive subpopulations) that is likely to be without appreciable risk ofdeleterious effect during a lifetime (10) . By contrast, the thresholds used as response factors could be effect specific and may also be time dependent (e.g., short term, chronic, etc.).
The use ofmathematical dose-response models for noncancer effects is not common, though such methods do exist. The methods proposed by Dourson et al. (7) and Crump (8) may be applied to estimate specific effects at given concentrations and to develop the "dose-response" thresholds discussed above. Additionally, some method ofassessing mixtures, considering both additivity and interactions, is also needed. A "mixture" doseresponse factor, should it prove possible, may be applied in column H of the framework.
Ideally, information presented in column H would include known thresholds as a function ofduration ofexposure. This is likely to be in a matrix format. Dose-response factors would also be presented for multiple organs and multiple effects. These factors would be presented for each of pollutants being evaluated. Should methods be developed, dose-response factors for mixtures or factors for adding effects from individual compounds would also be presented in column H.
Application to an Example Complex Mixture
The concepts and issues presented above represent the ideal information and data needs to conduct a thorough risk characterization ofnoncancer health effects. However, typically, this information is not available, nor are the dose-response factors available or accepted for noncancer effects. More typically, risk assessments are simplified due to data limitations. The framework will be applied to an example complex mixture to demonstrate its usefulness and to test each of the concepts and issues discussed above for a real problem. Table 1 were the major components identified in measurements taken from new material of the same batch stored within a warehouse. As off-gassing emissions from new products tend to decay over time, these measurement values are assumed to represent the maximum exposure levels. These compounds will be further evaluated and used in the characterization of noncancer risks. In addition, formaldehyde, acetaldehyde, and acetone have been identified as major constituents in other building materials used in the renovation, and concentrations represent estimated concentrations predicted by a model for worst-case building ventilation conditions.
Identification of Possible Health Effects
The initial efforts addressing health effects focused on a review of the TOXNET database for the compounds identified in Table 1 . Searches were made for each of the 10 compounds in the following fields: human toxicity excerpts; populations at special risk; absorption, distribution and excretion; metabolism/metabolites; biological half-life; mechanisms of action; interactions; and threshold limit values (TLVs). The reported effects have been summarized and are presented in Table 2 . Only observed human health effects were recorded to simplify the initial phase and to avoid introducing uncertainties associated with interspecies extrapolation.
The information presented in the matrix is not exhaustive, but is illustrative ofthe types ofhealth effects reported. Most ofthe information in TOXNET is from occupational exposures at concentrations much higher than that associated with indoor air pollutants. These effects or symptoms are not necessarily expected with any exposure to a given compound, but only indicate the range ofpossible effects. It should also be kept in mind that other effects may be possible, but have not been identified or, if they have been identified, not reported in TOXNET. This approach is limited by both reported information and the extent to which a compound has been studied. For example, comparing formaldehyde and 4-phenylcyclohexene (4-PCH), one would get the impression that formaldehyde is an important component and major contributor to health impacts from indoor air, whereas 4-PCH contributes nothing to these effects. While this may be true, study bias may be a more accurate explanation. Formaldehyde is one ofthe most studied compounds, having an extensive database, whereas no information is reported in TOX-NET on 4 (11) . TLVs and odor thresholds were found for all compounds except 4-PCH, for which only an odor threshold has been estimated, and are presented in Table  3 . Observed concentrations were several orders of magnitude lower than their respective TLVs, and odor thresholds were exceeded for three compounds (acetaldehyde, formaldehyde, and 4-PCH).
Theoretically, comparison of observed concentrations to any existing thresholds can be made for individual compounds. These thresholds can be for a wide range of effects. However, there are few data available on thresholds for health effects at low concentrations (in a controlled setting) which represents a severe limitation to this approach.
Mixture Index Values
All ofthe previous approaches have focused on the individual compounds and their respective health effects. It is desirable to develop some method ofassessing the mixture as a whole rather than the sum of its individual components (13) . The EPA has recommended several approaches in their Complex Mixture Risk Assessment Guidelines (14) . Based on the approaches suggested in the guidelines as well as a review of the literature of noncancer risk assessment, a proposed approach ofusing a mixture index value has been applied. There are several options for these mixture index values, which include: hazard index, margin of exposure, additivity (with relative potency), response addition, comparative potency and toxicity equivalent factors, total organics (or by chemical class), indicator compound concentrations, interactions, and tiered approach.
The hazard index, margin ofexposure, and additivity assume additivity ofeffects, and involve the summation ofhealth effects for individual compounds. Comparative potency is different in Table 2 . Summary of reported effects of various indoor air pollutants.
that the toxicity of the mixture is assessed directly without atten-tion oftotal health effects. Interactions are a formal approach for tion to individual components and is based on the assumption addressing the physiological effects individual compounds have that bioassays are applicable to human health prediction. Mix-on one another, either synergistically or antagonistically. The tures are compared on the basis ofbioassay results (15 
Conclusions
The noncancer risk characterization framework has shown promise. The initial efforts discussed here are preliminary and should lead to further development of noncancer risk characterization methodologies. The framework has proven to be a useful tool for displaying the complexity of noncancer risk characterization, integrating information for the various components ofa risk assessment from several sources, and evaluating data and information.
The framework (as depicted in Figure 1 ) lists the key issues specific to noncancer risk characterization. It displays the data and information needs to properly address noncancer health effects. Noncancer risk characterization differs from cancer risks primarily in the fact that noncancer health effects are multidimensional, with a wide range of health effects of varying severity affecting multiple organs. Columns I-J of the framework (Fig. 1) display -the desired end points in noncancer health effects characterization and how the effects should characterized. Columns C-Hof the framework (Fig. 1) show the data and information needs to carry out such a characterization.
The framework provides a formal mechanism to integrate information from several sources relating to exposure, dose response, and health effects. This was demonstrated in the application to the example complex mixture in which the framework facilitated the organization of data for source characterization, for constituents and their respective concentrations (Table 1) , corresponding to columns B and C (Fig. 1) , and for individual health effects reported in the exposed population and in the literature (e.g., Table 4 ), corresponding to columns I-Kof Figure 1 .
Following from the integration of information, the framework is also useful in evaluating the existence and quality of data and information. Related to the example complex mixture, existing data were available for columns B and C, pollutant source and concentration, and for columns I-K, individual health effects, exposed population, and population health effects. All data are considered to be preliminary and limited. Pollutant concentrations represent a maximum value off-gassing from the source and do not represent actual exposures. Health effects in the exposed population are limited to self-reported symptoms ofan anecdotal nature with few data on incidence in the overall population.
Several major data gaps are apparent from reviewing available information. There is a lack ofdata on exposure duration/setting (column D), exposure (column E), dose conversion factors (column F), dose-response factors (column H). Maximum concentrations are presented with little information on the actual concentrations of exposure and time-activity patterns for the exposed population, which limits the calculation ofexposure and dose. Also, there are limited data on noncancer dose-response factors, though this is an area receiving significant attention.
Preliminary efforts in developing and applying the framework have proven successful, though there is still a need for further refinement. The framework displays the complexity of the risk characterization process and the variety ofdata needs. It is useful in defining research needs and strategies (as in identifying the data gaps above) to obtain necessary data. The framework is particularly useful in pointing out data needs in a variety of disciplines and how these data need to be integrated to obtain a complete risk characterization. Such an approach can help to develop research strategies that are multidisciplinary and address the full range of issues relating to noncancer risk characterization.
